Nova Tina Susan
SEC insider (Form 3/4/5 filer). CIK 0001302605. Director at Aurinia Pharmaceuticals Inc. (AUPH) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in EDMONTON.
Companies Nova Tina Susan has filed insider reports for
- Aurinia Pharmaceuticals Inc. (AUPH): Director
- Azenta, Inc. (AZTA): Director
- EXAGEN INC. (XGN): Director
Nova Tina Susan
CIK: 0001302605
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 4, 2026AUPH
Aurinia Pharmaceuticals Inc.
AwardDirectDirector Stock Option (right to buy)
23.9K shares- - Feb 6, 2026AZTA
Azenta, Inc.
AwardDirect5.7K shares at avg. $27.85$158K - Jun 10, 2025XGN
EXAGEN INC.
AwardDirectStock Option(right to buy)
13.5K shares- - May 16, 2025AUPH
Aurinia Pharmaceuticals Inc.
AwardDirectDirector Stock Option (right to buy)
63.7K shares- - Feb 7, 2025AZTA
Azenta, Inc.
AwardDirect4K shares at avg. $52.32$211K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  AUPH Aurinia Pharmaceuticals Inc. | Award Director Stock Option (right to buy) | 23,931 | - | - | Direct |
| Feb 6, 2026 |  AZTA Azenta, Inc. | Award | 5,663 | $27.85 | $157,715 | Direct |
| Jun 10, 2025 |  XGN EXAGEN INC. | Award Stock Option(right to buy) | 13,500 | - | - | Direct |
| May 16, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Award Director Stock Option (right to buy) | 63,724 | - | - | Direct |
| Feb 7, 2025 | AZTA Azenta, Inc. | Award | 4,040 | $52.32 | $211,373 | Direct |
1-5 of 5 transactions